On August 28, 2023, representatives of JSC “National Holding QazBioPharm” met with representatives of Mindray in the People’s Republic of China during an international event organized at the initiative of SC-Pharmacy and Kazakh Invest. As part of the event, the parties visited the Mindray Manufacturing Center, where they were introduced to the full cycle of medical equipment production and discussed opportunities for further cooperation.

About Mindray: Mindray was founded in 1991 in Shenzhen, Guangdong Province. The company has grown through the production of patient monitoring systems, imaging devices, and other diagnostic products.

The company has earned international recognition and certifications in accordance with global standards, including TUV ISO9001/13485, CE, and FDA, demonstrating its ability to produce and develop world-class medical equipment.

Mindray began its activities with relatively simple patient monitoring devices and now offers one of the world’s broadest product lines, covering four main areas: PMLS (Patient Monitoring and Life Support Systems), MIS (Medical Imaging Systems), IVD (In Vitro Diagnostics), and Orthopedics.

Within a short period, the company has become a global leader in many fields through the acquisition of other companies and substantial investment of financial and human resources into technology development and the creation of new models. On average, Mindray launches 7 to 12 new models each year.